In addition, Hideaki Sato, President & CEO of Luxna Biotech Co., Ltd., will serve as chairperson for the Corporate Technology Symposium and participate in a mini-panel discussion with Mr. Takafumi Futami of AN Venture Partners and Mr. Shumpei Murata of Tanabe Pharma Corporation.

The details are as follows:

Symposium Presentation

Date and Time: July 7, 2026 (Tue), 11:15–11:30
Session: Symposium 1 (Chemistry)
Venue: Convention Hall 1 & 2
Presentation Number: O1-3

Title:
Chemical Optimization of Gapmer ASOs: 5′‑Cyclopropylene (5′‑CP) DNA Gap Modification as a Strategy to Minimize Off‑Target Activity

Authors:
Ryohei Kajino, Ph.D., Takaaki Kawanobe, Ph.D., and Ajaya Shrestha, Ph.D.

Poster Presentation

Date and Time: July 8, 2026 (Wed), 11:10–12:10
Venue: Convention Hall 3 & 4
Poster Number: P052

Title:
Optimization of Synthesis Conditions for 5′-Cyclopropylene (5′-CP)-Modified Oligonucleotides

Authors:
Junsuke Hayashi, Ph.D., Ryohei Kajino, Ph.D., and Ajaya Shrestha, Ph.D.

Corporate Technology Symposium

Date and Time: July 9, 2026 (Thu), 8:30–9:00
Venue: Convention Hall 1 & 2　C1

Speaker:
Takafumi Futami (AN Venture Partners)

Chairpersons:
Shumpei Murata (Tanabe Pharma Corporation)
Hideaki Sato (Luxna Biotech Co., Ltd.)

Overview:
Hideaki Sato, President & CEO of Luxna Biotech Co., Ltd., will serve as chairperson for the session. Following the presentation, he will participate in a mini-panel discussion with Mr. Takafumi Futami of AN Venture Partners and Mr. Shumpei Murata of Tanabe Pharma Corporation.

We warmly invite you to join our presentations and the Corporate Technology Symposium during the meeting. We look forward to meeting you in Nagasaki.

For more information about the meeting, please visit:

The 11th Annual Meeting of the Nucleic Acids Therapeutics Society of Japan (NATSJ)